RAS- Targeted Drug Discovery Europe Summit

RAS- Targeted Drug Discovery Europe Summit is organized by Hanson Wade and will be held from Feb 25 - 27, 2020 at Hilton Vienna Plaza, Vienna, Wien, Austria.

Description:
Uniting The European & International Anti-RAS Drug Development Community From Large Pharma, Innovative Biotech & KOLs Of Academia

With the diversity of therapeutic approaches to target RAS family of proteins growing rapidly and following the recent clinical progression of highly optimistic candidates, the RAS- Targeted Drug Discovery Summit Europe is coming to Vienna to showcase a full array of approaches to finally drug the “undruggable” RAS family of proteins. As part of a series of industry dedicated and translational focused meetings focused solely on anti-RAS drug discovery, this summit will be your opportunity to:

• HEAR from the leaders of the European and international anti-RAS drug discovery community as they develop divers tools and approaches to tackle the undruggable nature of RAS
• GAIN first-hand insights on challenges and strategies on how to robustly translate promising RAS inhibitors into clinical development and increase your success rate
• FORM lasting connections by engaging directly with colleagues from the leading pharma and biotech companies actively developing anti-RAS therapies and seeking the best solutions, in an intimate environment

Pre-Conference Workshop will be held on Feb 25, 2020
Main Conference will be held from Feb 26 - 27, 2020

Additional details will be posted as soon as information is available.